We hereby inform that Newgen Software Inc., material subsidiary incorporated in USA. has executed an agreement with a USA based Healthcare Client for Enterprise Content Management.
SMA Solar Technology AG gained 1.160% today. We see a rather positive sentiment for SMA Solar Technology AG with 8 Buy predictions and 1 Sell predictions. With a target price of 65 € there is ...
DeskTrading, a frontrunner in the SMA technology sector founded in 2010, is excited to announce a significant rebranding initiative in celebration of its 15th anniversary. This strategic move will ...
Talditercept alfa is under clinical development by Biohaven and currently in Phase III for Spinal Muscular Atrophy (SMA). According to GlobalData, Phase III drugs for Spinal Muscular Atrophy (SMA) ...